Bio-Techne (TECH) EBT Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 8.48% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.60% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 88.92% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 6.23% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 213.87% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 530.43% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -12.04% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 96.45% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 409.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 409.20% |
| Mar 31, 2026 | 86.09% |
| Dec 31, 2025 | 18.44% |
| Sep 30, 2025 | 19.47% |
| Jun 30, 2025 | -154.87% |
| Mar 31, 2025 | -37.34% |
| Dec 31, 2024 | 28.42% |
| Sep 30, 2024 | -18.94% |
| Jun 30, 2024 | -52.83% |
| Mar 31, 2024 | -23.83% |
| Dec 31, 2023 | -49.74% |
| Sep 30, 2023 | -52.22% |
| Jun 30, 2023 | 11.72% |
| Mar 31, 2023 | 16.61% |
| Dec 31, 2022 | -22.92% |
| Sep 30, 2022 | 53.92% |
| Jun 30, 2022 | 1,011.37% |
| Mar 31, 2022 | 51.63% |
| Dec 31, 2021 | 52.89% |
| Sep 30, 2021 | 71.29% |